IP Library › Granted Patent US 10,874,644
Granted Patent B2
US 10,874,644 · App. 16/433,097 · Granted Dec 29, 2020

Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function

Inventors: Daniel Cohen (Le Vesinet, FR); Ilya Chumakov (Vaux le Penil, FR); Serguei Nabirochkin (Chatenay Malabry, FR); Oxana Guerassimenko (Milly-la-Foret, FR); Nathalie Cholet (Meudon, FR)
Assignee: Pharnext
A61K31/42A61K31/155A61K31/255A61K45/06C07C279/26C07D261/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,874,644
App. No.
16/433,097
Granted
Dec 29, 2020
Kind
B2
Abstract

Compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, disclosed are combined therapies that modulate synapse function for treating the disease.

Claims (7)

1. A method of treating Lewy body dementia, the method comprising administering to a subject in need thereof an effective amount of zonisamide, or a salt or a sustained release formulation thereof.

2. The method of claim 1 , further comprising simultaneously, separately, or sequentially administering to a subject in need thereof at least one compound selected from the group of dyphylline, tadalafil, argatroban, acamprosate, cinacalcet, terbinafine, cilostazol, baclofen, phenformin, amlodipine and sulfisoxazole, or salts or sustained release formulations thereof.

3. The method of claim 1 , further comprising simultaneously, separately, or sequentially administering to a subject in need thereof at least one drug that modulates synapse function.

4. The method of claim 1 , further comprising simultaneously, separately, or sequentially administering to a subject in need thereof at least one drug that modulates angiogenesis.

5. The method of claim 1 , further comprising simultaneously, separately, or sequentially administering to a subject in need thereof at least one drug that modulates cell stress response.

6. The method of claim 1 , wherein the effective amount of zonisamide, or a salt or sustained release formulation thereof, is formulated with a pharmaceutically acceptable carrier or excipient.

7. The method of claim 1 , wherein the effective amount of zonisamide, or a salt or sustained release formulation thereof, is repeatedly administered to the subject.

Continuity (5)
Continuation 14954388 · Nov 30, 2015
Continuation 12915722 · Oct 29, 2010
Continuation In Part PCTEP2009055176 · Apr 29, 2009
Provisional Application 61048582 · Apr 29, 2008
Related Publication 20190298698A1 · Oct 3, 2019